nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Areflexia—Cisplatin—peripheral nervous system neoplasm	0.0485	0.0494	CcSEcCtD
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.0342	0.0348	CcSEcCtD
Potassium Canrenoate—Pregnancy—Tretinoin—peripheral nervous system neoplasm	0.0179	0.0182	CcSEcCtD
Potassium Canrenoate—Pregnancy—Isotretinoin—peripheral nervous system neoplasm	0.0179	0.0182	CcSEcCtD
Potassium Canrenoate—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.0163	0.0166	CcSEcCtD
Potassium Canrenoate—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.0163	0.0166	CcSEcCtD
Potassium Canrenoate—Slurred speech—Cisplatin—peripheral nervous system neoplasm	0.0147	0.0149	CcSEcCtD
Potassium Canrenoate—Pregnancy—Alitretinoin—peripheral nervous system neoplasm	0.0136	0.0138	CcSEcCtD
Potassium Canrenoate—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.0124	0.0126	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Cisplatin—peripheral nervous system neoplasm	0.0121	0.0124	CcSEcCtD
Potassium Canrenoate—Extravasation—Topotecan—peripheral nervous system neoplasm	0.0117	0.012	CcSEcCtD
Potassium Canrenoate—Extravasation—Melphalan—peripheral nervous system neoplasm	0.0115	0.0117	CcSEcCtD
Potassium Canrenoate—Dysarthria—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0109	CcSEcCtD
Potassium Canrenoate—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0109	CcSEcCtD
Potassium Canrenoate—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0109	CcSEcCtD
Potassium Canrenoate—Dysarthria—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0109	CcSEcCtD
Potassium Canrenoate—Ulcer—Melphalan—peripheral nervous system neoplasm	0.0106	0.0108	CcSEcCtD
Potassium Canrenoate—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.0105	0.0107	CcSEcCtD
Potassium Canrenoate—Ileus—Vincristine—peripheral nervous system neoplasm	0.0105	0.0107	CcSEcCtD
Potassium Canrenoate—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.00951	0.00969	CcSEcCtD
Potassium Canrenoate—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.00878	0.00894	CcSEcCtD
Potassium Canrenoate—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.00856	0.00872	CcSEcCtD
Potassium Canrenoate—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.00856	0.00872	CcSEcCtD
Potassium Canrenoate—Extravasation—Vincristine—peripheral nervous system neoplasm	0.0085	0.00866	CcSEcCtD
Potassium Canrenoate—Dysarthria—Alitretinoin—peripheral nervous system neoplasm	0.00814	0.00829	CcSEcCtD
Potassium Canrenoate—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.00814	0.00829	CcSEcCtD
Potassium Canrenoate—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.00752	0.00766	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00707	0.0072	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00701	0.00714	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00701	0.00714	CcSEcCtD
Potassium Canrenoate—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.00699	0.00712	CcSEcCtD
Potassium Canrenoate—Dysarthria—Cisplatin—peripheral nervous system neoplasm	0.00693	0.00706	CcSEcCtD
Potassium Canrenoate—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.00693	0.00706	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00692	0.00705	CcSEcCtD
Potassium Canrenoate—Extravasation—Etoposide—peripheral nervous system neoplasm	0.00689	0.00701	CcSEcCtD
Potassium Canrenoate—Drospirenone—BCHE—peripheral nervous system neoplasm	0.00678	0.369	CrCbGaD
Potassium Canrenoate—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.00648	0.00661	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Cisplatin—peripheral nervous system neoplasm	0.00644	0.00656	CcSEcCtD
Potassium Canrenoate—Ulcer—Etoposide—peripheral nervous system neoplasm	0.00635	0.00647	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Epirubicin—peripheral nervous system neoplasm	0.00624	0.00636	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00611	0.00622	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00611	0.00622	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.00577	0.00588	CcSEcCtD
Potassium Canrenoate—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00553	0.00563	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.00531	0.00541	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.00517	0.00526	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00514	0.00524	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00513	0.00522	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00513	0.00522	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.00512	0.00521	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.0051	0.0052	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.0051	0.0052	CcSEcCtD
Potassium Canrenoate—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00506	0.00516	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00506	0.00515	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00503	0.00513	CcSEcCtD
Potassium Canrenoate—Ileus—Epirubicin—peripheral nervous system neoplasm	0.00476	0.00485	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00463	0.00472	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.00456	0.00464	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.00456	0.00464	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.0045	0.00458	CcSEcCtD
Potassium Canrenoate—Ileus—Doxorubicin—peripheral nervous system neoplasm	0.0044	0.00448	CcSEcCtD
Potassium Canrenoate—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00437	0.00446	CcSEcCtD
Potassium Canrenoate—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00437	0.00446	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00415	0.00422	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00394	0.00402	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00388	0.00396	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00386	0.00394	CcSEcCtD
Potassium Canrenoate—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.00386	0.00393	CcSEcCtD
Potassium Canrenoate—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00376	0.00383	CcSEcCtD
Potassium Canrenoate—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00373	0.0038	CcSEcCtD
Potassium Canrenoate—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00373	0.0038	CcSEcCtD
Potassium Canrenoate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00365	0.00372	CcSEcCtD
Potassium Canrenoate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00365	0.00372	CcSEcCtD
Potassium Canrenoate—Infection—Topotecan—peripheral nervous system neoplasm	0.00363	0.0037	CcSEcCtD
Potassium Canrenoate—Infection—Tretinoin—peripheral nervous system neoplasm	0.0036	0.00367	CcSEcCtD
Potassium Canrenoate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.0036	0.00367	CcSEcCtD
Potassium Canrenoate—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00357	0.00364	CcSEcCtD
Potassium Canrenoate—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00363	CcSEcCtD
Potassium Canrenoate—Dysarthria—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00363	CcSEcCtD
Potassium Canrenoate—Infection—Melphalan—peripheral nervous system neoplasm	0.00355	0.00362	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.00347	0.00354	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00345	0.00352	CcSEcCtD
Potassium Canrenoate—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00339	0.00345	CcSEcCtD
Potassium Canrenoate—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00339	0.00345	CcSEcCtD
Potassium Canrenoate—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00334	0.0034	CcSEcCtD
Potassium Canrenoate—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00332	0.00338	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.00331	0.00337	CcSEcCtD
Potassium Canrenoate—Dysarthria—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00336	CcSEcCtD
Potassium Canrenoate—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00336	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00328	0.00334	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00325	0.00331	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00325	0.00331	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.00321	0.00327	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00321	0.00327	CcSEcCtD
Potassium Canrenoate—Pain—Topotecan—peripheral nervous system neoplasm	0.00312	0.00318	CcSEcCtD
Potassium Canrenoate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0031	0.00316	CcSEcCtD
Potassium Canrenoate—Pain—Tretinoin—peripheral nervous system neoplasm	0.0031	0.00316	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00306	0.00312	CcSEcCtD
Potassium Canrenoate—Pain—Melphalan—peripheral nervous system neoplasm	0.00306	0.00312	CcSEcCtD
Potassium Canrenoate—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00305	0.00311	CcSEcCtD
Potassium Canrenoate—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.00304	0.165	CrCbGaD
Potassium Canrenoate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00301	0.00307	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00299	0.00304	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00299	0.00304	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00299	0.00304	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00296	0.00302	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00296	0.00302	CcSEcCtD
Potassium Canrenoate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00294	0.003	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00294	0.003	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00289	0.00294	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00289	0.00294	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00292	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00292	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00292	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00292	CcSEcCtD
Potassium Canrenoate—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00284	0.00289	CcSEcCtD
Potassium Canrenoate—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.00288	CcSEcCtD
Potassium Canrenoate—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00282	0.00288	CcSEcCtD
Potassium Canrenoate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00277	0.00282	CcSEcCtD
Potassium Canrenoate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00278	CcSEcCtD
Potassium Canrenoate—Infection—Vincristine—peripheral nervous system neoplasm	0.00263	0.00268	CcSEcCtD
Potassium Canrenoate—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.00267	CcSEcCtD
Potassium Canrenoate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00262	0.00267	CcSEcCtD
Potassium Canrenoate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0026	0.00265	CcSEcCtD
Potassium Canrenoate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0026	0.00265	CcSEcCtD
Potassium Canrenoate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00257	0.00261	CcSEcCtD
Potassium Canrenoate—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00257	0.00261	CcSEcCtD
Potassium Canrenoate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00253	0.00258	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.0025	0.00255	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00253	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00253	CcSEcCtD
Potassium Canrenoate—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00247	0.00252	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00251	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00245	0.00249	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00244	0.00249	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00242	0.00247	CcSEcCtD
Potassium Canrenoate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00241	0.00246	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00238	0.00242	CcSEcCtD
Potassium Canrenoate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00239	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00234	0.00238	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00234	0.00238	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00237	CcSEcCtD
Potassium Canrenoate—Infection—Cisplatin—peripheral nervous system neoplasm	0.00232	0.00237	CcSEcCtD
Potassium Canrenoate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00232	0.00237	CcSEcCtD
Potassium Canrenoate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0023	0.00235	CcSEcCtD
Potassium Canrenoate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.00235	CcSEcCtD
Potassium Canrenoate—Rash—Topotecan—peripheral nervous system neoplasm	0.0023	0.00235	CcSEcCtD
Potassium Canrenoate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0023	0.00234	CcSEcCtD
Potassium Canrenoate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00233	CcSEcCtD
Potassium Canrenoate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00233	CcSEcCtD
Potassium Canrenoate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00233	CcSEcCtD
Potassium Canrenoate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00233	CcSEcCtD
Potassium Canrenoate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00227	0.00232	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00231	CcSEcCtD
Potassium Canrenoate—Pain—Vincristine—peripheral nervous system neoplasm	0.00226	0.0023	CcSEcCtD
Potassium Canrenoate—Rash—Melphalan—peripheral nervous system neoplasm	0.00225	0.0023	CcSEcCtD
Potassium Canrenoate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00225	0.00229	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00229	CcSEcCtD
Potassium Canrenoate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00221	0.00225	CcSEcCtD
Potassium Canrenoate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00219	0.00223	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00221	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00221	CcSEcCtD
Potassium Canrenoate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00217	0.00221	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00216	0.0022	CcSEcCtD
Potassium Canrenoate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00216	0.0022	CcSEcCtD
Potassium Canrenoate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00215	0.00219	CcSEcCtD
Potassium Canrenoate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00215	0.00219	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00219	CcSEcCtD
Potassium Canrenoate—Infection—Etoposide—peripheral nervous system neoplasm	0.00213	0.00217	CcSEcCtD
Potassium Canrenoate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Potassium Canrenoate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.0021	0.00214	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00209	0.00213	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00209	0.00213	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00203	0.00206	CcSEcCtD
Potassium Canrenoate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.002	0.00204	CcSEcCtD
Potassium Canrenoate—Pain—Cisplatin—peripheral nervous system neoplasm	0.002	0.00204	CcSEcCtD
Potassium Canrenoate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00201	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00196	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00192	0.00196	CcSEcCtD
Potassium Canrenoate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0019	0.00193	CcSEcCtD
Potassium Canrenoate—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.00189	0.103	CrCbGaD
Potassium Canrenoate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00188	0.00192	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00191	CcSEcCtD
Potassium Canrenoate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00187	0.0019	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00185	0.00188	CcSEcCtD
Potassium Canrenoate—Pain—Etoposide—peripheral nervous system neoplasm	0.00183	0.00187	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00181	0.00184	CcSEcCtD
Potassium Canrenoate—Prednisone—ABCB1—peripheral nervous system neoplasm	0.00178	0.0969	CrCbGaD
Potassium Canrenoate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00177	0.0018	CcSEcCtD
Potassium Canrenoate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00179	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00175	0.00179	CcSEcCtD
Potassium Canrenoate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00178	CcSEcCtD
Potassium Canrenoate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00176	CcSEcCtD
Potassium Canrenoate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00176	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.0017	0.00173	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00169	0.00173	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00169	0.00173	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00172	CcSEcCtD
Potassium Canrenoate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00168	0.00171	CcSEcCtD
Potassium Canrenoate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00171	CcSEcCtD
Potassium Canrenoate—Rash—Vincristine—peripheral nervous system neoplasm	0.00167	0.0017	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00167	0.0017	CcSEcCtD
Potassium Canrenoate—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.00164	0.0893	CrCbGaD
Potassium Canrenoate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0016	0.00163	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.0016	CcSEcCtD
Potassium Canrenoate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00157	0.0016	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00156	0.00159	CcSEcCtD
Potassium Canrenoate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00154	0.00157	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00154	CcSEcCtD
Potassium Canrenoate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00152	CcSEcCtD
Potassium Canrenoate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00148	0.0015	CcSEcCtD
Potassium Canrenoate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00147	0.0015	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00147	0.00149	CcSEcCtD
Potassium Canrenoate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00148	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00142	CcSEcCtD
Potassium Canrenoate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00142	CcSEcCtD
Potassium Canrenoate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00136	0.00139	CcSEcCtD
Potassium Canrenoate—Rash—Etoposide—peripheral nervous system neoplasm	0.00135	0.00138	CcSEcCtD
Potassium Canrenoate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00135	0.00138	CcSEcCtD
Potassium Canrenoate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00137	CcSEcCtD
Potassium Canrenoate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00127	0.0013	CcSEcCtD
Potassium Canrenoate—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.00126	0.0683	CrCbGaD
Potassium Canrenoate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Potassium Canrenoate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Potassium Canrenoate—Infection—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00122	CcSEcCtD
Potassium Canrenoate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Potassium Canrenoate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Potassium Canrenoate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Potassium Canrenoate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00113	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Potassium Canrenoate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00106	CcSEcCtD
Potassium Canrenoate—Pain—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Potassium Canrenoate—Progesterone—ABCB1—peripheral nervous system neoplasm	0.00102	0.0557	CrCbGaD
Potassium Canrenoate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000998	0.00102	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00099	0.00101	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000982	0.001	CcSEcCtD
Potassium Canrenoate—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000968	0.0526	CrCbGaD
Potassium Canrenoate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000951	0.000968	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00095	0.000968	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00095	0.000968	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000916	0.000933	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000909	0.000926	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.000895	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.000895	CcSEcCtD
Potassium Canrenoate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000862	0.000878	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000822	0.000837	CcSEcCtD
Potassium Canrenoate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000798	0.000813	CcSEcCtD
Potassium Canrenoate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000764	0.000778	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000761	0.000775	CcSEcCtD
Potassium Canrenoate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000758	0.000772	CcSEcCtD
Potassium Canrenoate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000757	0.000771	CcSEcCtD
Potassium Canrenoate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000714	0.000727	CcSEcCtD
Potassium Canrenoate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000707	0.00072	CcSEcCtD
Potassium Canrenoate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000701	0.000714	CcSEcCtD
Potassium Canrenoate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.000713	CcSEcCtD
Potassium Canrenoate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.000673	CcSEcCtD
